IP Library Granted Patent US 9,066,864
Granted Patent B2
US 9,066,864 · App. 13/979,231 · Granted Jun 30, 2015

Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions

Inventors: Hans Peter Niedermann (Bubenheim, DE); Heiko Bothe (Saulheim, DE)
Assignee: Intervet Inc.
A61K9/10A61K31/546A61K47/06A61K47/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,066,864
App. No.
13/979,231
Granted
Jun 30, 2015
Kind
B2
Abstract

Disclosed is a method of making particles of a drug wherein use is made of diafiltration. The diafiltration can be with anti-solvent, in which case a precipitate is obtained of particles as such. The diafiltration can also be with a pharmaceutically acceptable suspension medium. In that case several process steps of isolating, drying, transporting of particles can be avoided, because the suspension resulting from the synthesis of the particles is directly turned into a final drug product formulation.

Claims (12)

1. A method of making a pharmaceutical composition comprising particles of a drug, wherein the drug is initially produced in the form of a suspension in a first liquid medium, wherein the suspension is subjected to cross-flow filtration against a further liquid medium, said further liquid medium being a pharmaceutically acceptable media capable of retaining the drug as a suspension,

wherein the suspension in the first liquid medium is subjected to cross-flow filtration against a second liquid medium so as to obtain a suspension in the second liquid medium, said suspension in the second liquid medium being subjected to crossflow filtration against the pharmaceutically acceptable liquid medium, wherein the first liquid medium is acetone, a mixture of acetone and water or fractionated vegetable oil, wherein the second liquid medium is acetone, a mixture of acetone and water, fractionated vegetable oil or ethyl oleate, wherein the pharmaceutically acceptable media is paraffin or ethyl oleate; and

wherein when the first liquid medium is acetone, the second liquid medium is not acetone, when the first liquid medium is acetone and water, the second liquid medium is not acetone and water and when the first liquid medium is fractionated vegetable oil, the second liquid medium is not fractionated vegetable oil, and when the second liquid medium is ethyl oleate, the pharmaceutically acceptable media is not ethyl oleate.

2. The method according to claim 1 , wherein the further liquid medium is a pharmaceutically acceptable medium capable of retaining the drug in suspension, and the produced composition comprising particles of a drug is a suspension of the drug in a pharmaceutically acceptable liquid medium.

3. The method according to claim 1 , wherein the second liquid medium is selected from the group consisting of ethyl oleate and fractionated vegetable oil, and the further liquid medium is liquid paraffin.

4. The method of claim 1 , wherein the drug is a cephalosporin antibiotic.

5. The method according to claim 2 , wherein the drug is a cephalosporin antibiotic.

6. The method according to claim 1 , wherein the drug is a cephalosporin antibiotic and the first liquid medium is acetone or a mixture of acetone and water and the pharmaceutically acceptable medium is ethyl oleate.

7. The method according to claim 1 , wherein the drug is a cephalosporin antibiotic and the first liquid medium is fractionated vegetable oil, the second liquid medium is acetone or a mixture of acetone and water and the pharmaceutically acceptable medium is liquid paraffin.

8. The method of claim 1 , wherein the fractionated vegetable oil is capric/caprylic triglycerides or propylene glycol dicaprylate/caprate.

9. The method of claim 3 , wherein the fractionated vegetable oil is capric/caprylic triglycerides or propylene glycol dicaprylate/caprate.

10. The method of claim 7 , wherein the fractionated vegetable oil is capric/caprylic triglycerides or propylene glycol dicaprylate/caprate.

Assignments (3)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2014
From: INTERVET INTERNATIONAL B.V.
To: INTERVET INC.
Reel/Frame 032153/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2014
From: NIEDERMANN, HANS PETER; BOTHE, HEIKO
To: INTERVET INTERNATIONAL B.V.
Reel/Frame 032101/0079 →
Continuity (2)
Provisional Application 61431942 · Jan 12, 2011
Related Publication 20130281425A1 · Oct 24, 2013